Severe local skin reaction after the application of ingenol mebutate gel treated by photodynamic therapy: A case report

  • Luca Negosanti S.Orsola-Malpighi University Hospital
  • Rossella Sgarzani Division of Plastic Surgery, S.Orsola-Malpighi University Hospital, Bologna, Italy.
  • Matteo Santoli Division of Plastic Surgery, Bellaria Hospital, Bologna, Italy.
  • Massimino Negosanti Division of Dermatology, S.Orsola-Malpighi University Hospital, Bologna, Italy
  • Nicoletta Banzola Division of Dermatology, S.Orsola-Malpighi University Hospital, Bologna, Italy
  • Francesca Negosanti Division of Dermatology, Centro Dermatologico Srl, Bologna, Italy.
DOI: https://doi.org/10.18282/jsd.v1.i1.36
Keywords: actinic keratosis, ingenol mebutate, photodynamic therapy

Abstract

Ingenol mebutate (IM) was recently introduced for the treatment of actinic keratosis (AK). It is considered a safe and effective treatment in spite of local reactions frequently reported. These reactions may consist of erythema, flaking, crusting, swelling, vesicles and erosions, and would usually spontaneously recede within 20–30 days. We reported a case of a patient affected by multiple actinic keratosis of the scalp treated with IM. The patient reported a severe reaction that was not solved in two months. We decided to treat the reaction with photodynamic therapy and aminolevulinic acid. This treatment was demonstrated to be effective in solving this severe side effect.

References

Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, et al. Ingenol mebutate gel for actinic keratosis. N Engl J Med 2012; 366: 1010–1019. doi: 10.1056/NEJMoa1111170.

Longo C, Neri L, Argenziano G, Calvieri S, Calzavara- Pinton PG, et al. Management of local skin reactions after the application of ingenol mebutate gel for the treatment of actinic keratosis: Four illustrative cases. J Eur Acad Der-matol Venereol 2014; 30(2): 320–321. doi:10.1111/jdv. 12714.

Negosanti L, Pinto V, Sgarzani R, Negosanti F, Zannetti G, et al. Photodynamic therapy with topical aminolevulinic acid. World J Dermatol 2014; 3(2): 6–14. doi: 10.5314/ wjd.v3.i2.6.

Berman B, Nestor MS, Newburger J, Park H, Swenson N. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebu-tate 0.015% gel with and without prior treatment with ALA-PDT. J Drugs Dermatol 2014; 13(11): 1353–1356.

Pariser DM, Eichenfield LF, Bukhalo M, Waterman G, Jarratt M, et al. Photodynamic therapy with 80 mg/g me-thyl aminolaevulinate for severe facial acne vulgaris: A randomised vehicle-controlled study. Br J Dermatol 2015. doi: 10.1111/bjd.14345.

Published
2017-10-17
Issue
Vol. 3 No. 1 (2018)
Section
Case Reports

Copyright (c) 2018 Negosanti L, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Author(s) shall retain the copyright of their work and grant the Journal/Publisher rights for the first publication with the work concurrently licensed under the Creative Commons Attribution-Noncommercial 4.0 International License

Under this license, author(s) will allow third parties to download, reuse, reprint, modify, distribute and/or copy the content under the condition that the authors are given credit and that the work is not used for commercial purposes. No permission is required from the authors or the publisher.

This broad license intends to facilitate free access, as well as the unrestricted use of original works of all types. This ensures that the published work is freely and openly available in perpetuity.